Sorafenib-Induced Liver Failure: A Case Report and Review of the Literature

In patients with hepatocellular carcinoma characterized by vascular invasion and/or extrahepatic disease, Sorafenib is considered treatment of choice. Although mild liver test abnormalities were reported in less than 1% of the patients in the two large randomized, controlled phase III trials, four c...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Hootegem, Anneleen, Verslype, Chris, Van Steenbergen, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411881/
https://www.ncbi.nlm.nih.gov/pubmed/25954549
http://dx.doi.org/10.1155/2011/941395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411881/
https://www.ncbi.nlm.nih.gov/pubmed/25954549
http://dx.doi.org/10.1155/2011/941395

Ejemplares similares